Company intelligence / Profile preview

Lazurite

Cleveland, Ohio, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Lazurite develops and commercializes ArthroFree, the first FDA 510(k)-cleared fully wireless surgical camera system for arthroscopy and general endoscopy, now in commercial use following FDA clearance in March 2022 and first surgeries beginning September 2022.[5][9]

Modalities: DeviceNon-pharmacological therapy
Industry: Surgical Medical Devices

Partnerships

The Center for Health Affairs (Northeast Ohio hospitals association)[5]CHAMPS Group Purchasing[1][5]Hospital for Special Surgery (HSS), New York[5]University Hospitals of Cleveland[3][5]LG Electronics USA[5]

Beyond the preview

Go deeper on Lazurite.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lazurite.

Explore the full profile